Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 2, 2011, Pages 163-172

  Vescini, Fabio ^a   Cozzi Lepri, Alessandro ^b,c   Borderi, Marco ^d   Re, Maria Carla ^d   Maggiolo, Franco ^e   De Luca, Andrea ^f   Cassola, Giovanni ^g   Vullo, Vincenzo ^h   Carosi, Giampiero ⁱ   Antinori, Andrea ^j   Tozzi, Valerio ^j   Monforte, Antonella D'Arminio ^k  

^a Mineral Metabolism Unit Gorizia Civil Hospital   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Division of Infectious Diseases Riuniti Hospital   (Italy)

^f UNIVERSITY OF SIENA   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SPEDALI CIVILI   (Italy)

^j NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^k UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

HIV infection; prognosis; vitamin D deficiency and insufficiency

Indexed keywords

ANTIRETROVIRUS AGENT; VITAMIN D;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONCENTRATION (PARAMETERS); DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SURVIVAL RATE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AFRICA; AGED; ANTI-RETROVIRAL AGENTS; CARDIOVASCULAR DISEASES; CENTRAL AMERICA; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; ITALY; LINEAR MODELS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEASONS; SOUTH AMERICA; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 80052961290     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31822e57e9     Document Type: Article

References (32)

1. Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int. 2009;20: 239-244.
2. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16:713-716. (Pubitemid 40933586)
3. Bischoff-Ferrari HA, Giovannucci E, Willett WC, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84:18-28. (Pubitemid 44699167)
4. Parker J, Hashmi O, Dutton D, et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas. 2010; 65:225-236.
5. Pilz S, Marz W, Wellnitz B, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927-3935.
6. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-314.
7. Pittas AG, Lau J, Hu FB, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017-2029. (Pubitemid 46997093)
8. Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol. 2008;52:1949-1956.
9. Kuchuk NO, van Schoor NM, Pluijm SM, et al. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res. 2009;24:693-701.
10. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168: 1340-1349. (Pubitemid 351930842)
11. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest. 2006;116:2062-2072. (Pubitemid 44162310)
12. Muszkat P, Camargo MB, Griz LH, et al. Evidence-based non-skeletal actions of vitamin D. Arq Bras Endocrinol Metabol. 2010;54:110-117.
13. Rodriguez M, Daniels B, Gunawardene S, et al. High frequency of vitamin D deficiency in ambulatory HIV-Positive patients. AIDS Res Hum Retroviruses. 2009;25:9-14.
14. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24: 1375-1382.
15. Villamor E. A potential role for vitamin D on HIV infection? Nutr Rev. 2006;64:226-233. (Pubitemid 43953286)
16. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20: 2165-2174. (Pubitemid 44684707)
17. Mondy K, Yarasheski K, Powderly WG, et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003;36:482-490. (Pubitemid 36241317)
18. Vescini F, Borderi M, Buffa A, et al. Bone mass in HIV-infected patients: focus on the role of therapy and sex. J Acquir Immune Defic Syndr. 2003;33:405-407. (Pubitemid 36859068)
19. Grund B, Peng G, Gibert CL, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009;23:1519-1529.
20. Calmy A, Fux CA, Norris R, et al. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis. 2009;200:1746-1754.
21. Arnsten JH, Freeman R, Howard AA, et al. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007;21:617-623.
22. Mueller NJ, Fux CA, Ledergerber B, et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS. 2010;24:1127-1134.
23. Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q J Nucl Med Mol Imaging. 2004;48:39-48. (Pubitemid 39069663)
24. Zhou C, Assem M, Tay JC, et al. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest. 2006;116:1703-1712.
25. d'Arminio Monforte A, Lepri AC, Rezza G, et al. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients. AIDS. 2000;14:499-507. (Pubitemid 30209692)
26. Lattuada E, Lanzafame M, Zoppini G, et al. No influence of nevirapine on vitamin D deficiency in HIV-infected patients. AIDS Res Hum Retroviruses. 2009;25:849-850.
27. Isaia G, Giorgino R, Rini GB, et al. Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int. 2003;14:577-582. (Pubitemid 36975557)
28. Cigolini M, Miconi V, Soffiati G, et al. Hypovitaminosis D among unselected medical inpatients and outpatients in Northern Italy. Clin Endocrinol (Oxf). 2006;64:475.
29. Tangpricha V, Pearce EN, Chen TC, et al. Vitamin D insufficiency among free-living healthy young adults. Am J Med. 2002;112:659-662. (Pubitemid 34597167)
30. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76:187-192. (Pubitemid 34686565)
31. Holick MF. The uderappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002;9: 87-98. (Pubitemid 34747893)
32. Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol. 2008;19:844-846.